Skip to content

Anticipating Decline and Providing Therapy

Anticipating Decline and Providing Therapy (ADAPT): Post-ICU Cognitive Screening Pilot and Feasibility Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06182995
Acronym
ADAPT
Enrollment
109
Registered
2023-12-27
Start date
2024-03-08
Completion date
2027-02-01
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment, Cognitive Impairment, Mild, Critical Illness, Dementia, Post ICU Syndrome

Keywords

Post ICU, Post-ICU Screening, older adults, aging

Brief summary

This pilot feasibility study will be a randomized control trial of usual care following Intensive Care Unit (ICU) discharge compared to the Anticipating Decline and Providing Therapy (ADAPT) screening and support intervention. The trial aims to enroll 120 older adults (age 60 or older).

Detailed description

Anticipating Decline and Providing Therapy (ADAPT) is a program designed to support the implementation of a routine post-ICU cognitive impairment screening and support intervention. The program includes a routine validated cognitive screen for high-risk older adults at 6 weeks and 6 months post-ICU discharge. Patients with a screening assessment that may be consistent with cognitive impairment or dementia will receive additional resources including a specialized care plan developed by the Sticht Center for Healthy Aging and Alzheimer's Prevention. The specialized care plan is adapted from a health system-based dementia care intervention and designed to support post-ICU cognitive concerns. It was adapted with input from geriatrics, intensive care, and outpatient primary care clinicians. Also conducted are semi-structured interviews with 22 older adult ICU survivors and 6 primary care physicians to elicit preferences and the intervention was further adapted based on these results.

Interventions

BEHAVIORALUsual Care post-Intensive Care Unit (ICU)

routine clinic visits

BEHAVIORALAnticipating Decline and Providing Therapy (ADAPT)

routine validated cognitive screen for high-risk older adults at 6 weeks and 6 months post-ICU discharge

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Target sample size is 120 participants, randomized 1:1 to usual care or Anticipating Decline and Providing Therapy (ADAPT) arm.

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 60 and older at time of discharge from intensive care unit * Minimum 72 hour Intensive Care Unit stay in an ICU at Atrium Health Wake Forest Baptist * Delirium during ICU stay as determined by positive Confusion Assessment Method (CAM)-ICU score, review of clinical - documentation, or discussion with clinical team * Primary care provider in the Atrium Health Wake Forest system or intention to follow with Primary Care Physician in Atrium Health system * English speaking

Exclusion criteria

* Death during initial hospitalization and/or discharge to Hospice * Life-expectancy \< 6 months from pre-existing illness (defined as diagnosis of metastatic cancer, cirrhosis, advanced heart failure, prior palliative care referral) * Acute Traumatic Brain Injury * Continued residence in skilled nursing facility or rehab that prevents ability to complete study telephone call at time of first cognitive screen attempt * Prior history of dementia in electronic health record * Language or communication barrier that prohibits intervention participation * Participant cannot identify family or caregiver contact or family/caregiver unwilling to participate * Subject or legally authorized representative (LAR) decline consent * Unstable telephone service for contact after hospital discharge * Primary residence outside of North Carolina

Design outcomes

Primary

MeasureTime frameDescription
Number of participants in Cognitive Screening Intervention ArmWeek 6Number of participants in intervention arm who complete cognitive screening at 6 weeks

Secondary

MeasureTime frameDescription
Change in Percentage of participants having mild cognitive impairment (MCI), probable dementia and the combination of either MCI or probable dementiaWeek 28percentage of participants adjudicated as having mild cognitive impairment (MCI), probable dementia and the combination of either MCI or probable dementia
Change in number of Participants between those enrolled and those who were eligible but declinedWeek 52compare pre-specified baseline characteristics (i.e., age, sex, race, ICU length of stay) between those enrolled and those who were eligible but declined
Number of eligible participants who complete specialized care plan development visitup to week 28Number of eligible participants who complete specialized care plan development visit
Change in Modified Caregiver Strain Index (MCSI) ScoresWeek 28the modified caregiver strain index will be assessed via telephone call to identified caregiver or care partner in both groups - a 13-question tool that measures strain related to care provision - Scoring is 2 points for each 'yes', and 1 point for each 'sometimes' response. The higher the score, the higher the level of caregiver strain - range of 13-26
Change in the number of hospitalizations and Emergency Department visitsMonth 12healthcare utilization will be the number of hospitalizations and Emergency Department (ED) visits
Change in the Number of neuropsychiatric prescriptions medicationsMonth 12number of neuropsychiatric prescriptions medications will be measured using the electronic health record
Change in number of new diagnoses of dementia or mild cognitive impairmentMonth 12new diagnosis of dementia or mild cognitive impairment will be measured using the electronic health record
Acceptability of Intervention Measure (AIM) ScoresWeek 28The Acceptability of Intervention Measure (AIM) - Response Scale - 4 item scales. Each item will be measured on a 5 point Likert scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree - The score is calculated mean. Higher scores reflect higher measure of acceptability
Acceptability of Intervention Appropriateness Measure (IAM) ScoresWeek 28Intervention Appropriateness Measure (IAM) - Response Scale - 4 item scales. Each item will be measured on a 5 point Likert scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree - The score is calculated mean. Higher scores reflect higher measure of appropriateness
Acceptability of Feasibility of Intervention measure (FIM) ScoresWeek 28The Acceptability of Feasibility of Intervention Measure (FIM) - Response Scale - 4 item scales. Each item will be measured on a 5 point Likert scale: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree - The score is calculated mean. Higher scores reflect higher measure of feasibility

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJessica Palakshappa, MD

Wake Forest University Health Sciences

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026